Navigation Links
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
Date:4/30/2013

576$
54,818$
5,669$
,487Provision for income taxes$
28,494$
(4,366)

(d)

$
24,128$
9,448$
5,580

 (f) 

$
5,028Net income$
5,931$
5,517$
71,448$
45,370$
89$
45,459Diluted earnings per common share$
.10$
.09$
.19$
.75$
.00$
.75Effective tax rate30.2%25.2%17.2%24.8%(a) Adjustment includes $1.9 million in legal charges related to disputes and $0.7 million in acquisition and integration charges related to Liquent, Inc.(b) Decrease in facility-related charges of $1.2 million related to restructuring plans(c) Adjustment includes $0.4 million gain on facility sale previously impaired and $0.1 million in accelerated amortization of deferred financing fees related to credit facility modification(d) Tax associated with items (a) through (c), a tax expense for one-time adjustments to deferred tax assets in Q1 FY13,  a net $2.7 million expense due to changes in interest, penalties and a valuation allowance in a foreign jurisdiction in Q2 FY13, and a $0.5 million adjustment due to state valuation allowance release in Q3 FY13(e) Restructuring charges include $4.5 million in severance costs (net of a $1.0 million reduction in the FY10 Plan) and $1.2 million of facility-related costs(f) Tax associated with item (e) and a $4.2 million benefit in Q3 FY12 due to the favorable conclusion of a tax examination and expiration of statutory periods, primarily in European jurisdictions 

 PAREXEL International CorporationSegment InformationUnauditedThree Months EndedThree Months Ended(in thousands)3/31/20133/31/2012Clinical Research Services (CRS)Service revenue $
342,387$
263,372% of total service revenue75.3%74.0%Gross profit$
95,505$
74,852Gross margin % of service revenue27.9%28.4%PAREXEL Consulting & Medical Communications  Services (PCMS)Service revenue
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. PAREXEL International to Present at J.P. Morgan Healthcare Conference
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
5. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
6. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
7. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
8. PAREXEL International to Present at Morningstar Conference
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
10. UV Flu Technologies Expands Its International Footprint
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... Patent Offering, The patent’s technology pertains to an ... within a body lumen (open space). Known as ... cost, single-use disposable illumination and camera module (housing). ... and the patent approval was received on January 6, ... the lighting and magnification of the endoscope for different ...
(Date:5/21/2015)... 2015 Veolia’s environmental monitoring technology ... American distribution agreement with VWR to distribute TECTA™ ... more than 160 years of experience, VWR, a ... laboratory and production facilities, has cultivated a value ... services to enable science. Endetec’s TECTA™ B16, ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has announced ... Outlook 2020 " report to their offering. ... medicine is expected to have huge marketing potential. Presently, ... the growth of deregulated organs. Several therapeutic molecules are ... form new tissue or sometimes organ transplant is required. ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... 5 BioMarin,Pharmaceutical Inc. (Nasdaq: BMRN ) today ... present a company,update at the Credit Suisse 2008 Annual ... at 10:30 a.m. MST., Interested parties may access ... investor section of the BioMarin website, http://www.BMRN.com .,A ...
... (Nasdaq: PPHM ) today announced that senior ... Annual Healthcare Conference on,Tuesday, November 11, 2008 at ... at,the New York Palace Hotel in New York ... please visit:, http://www.rodmanandrenshaw.com/conferences?id=19 , About Peregrine Pharmaceuticals, ...
... EDMONTON, Nov. 5 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: ... today,announced that Mr. Kevin Giese, President and CEO, will present ... York., WHEN: Monday November ... New York Palace Hotel, New York., About BioMS Medical ...
Cached Biology Technology:BioMarin to Present at the Credit Suisse Healthcare Conference 2BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference 2
(Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/19/2015)... DUBLIN , May 19, 2015 /PRNewswire/ ... ) has announced the addition of the  ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A ... provides an in-depth analysis of the current ... introduction of gene-based tests, their working principles ...
(Date:5/14/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) ... Market in Smart Mobile Devices " report to ... was a watershed year for fingerprint sensors in smartphones ... Apple gave fingerprint sensors a raison d,etre in the ... are a must-have feature in flagship smartphones. ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... that advanced biofuels made from cellulosic biomass are the ... renewable, clean, green, domestic source of transportation energy. Nature, ... sugars in grains, the complex polysaccharides in the cellulose ... woody material called lignin. For advanced biofuels to be ...
... Why do people with a hereditary mutation of the ... sickle-cell anemia prevalent in Africa) not contract severe malaria? ... of the Department of Infectious Diseases at Heidelberg University ... of the altered hemoglobin provides protection from severe malaria. ...
... recovery at one minute after a six-minute walking distance (6MWD) ... clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), ... first study to show that heart rate recovery at one ... strong predictor of clinical worsening in IPAH patients," said Omar ...
Cached Biology News:A corny turn for biofuels from switchgrass 2A corny turn for biofuels from switchgrass 3Protection from severe malaria explained 2Protection from severe malaria explained 3Heart rate recovery predicts clinical worsening in pulmonary hypertension 2
... Wellwash AC is the easiest to ... is provided with liquid level sensors ... The integrated orbital shaker and automatic ... washing performance. The big bottle model ...
... Thermo Electron RapidStak provides valuable walk-away time ... unique buffer nest technology for parallel processing ... provides fast, reliable automation for any laboratory ... confidence. The RapidStak can be set-up within ...
... polyclonal to MLF1 Interacting Protein/PBIP1 (phospho ... tested applications). Antigen: ... amino acids 73-83 of Human MLF1 ... Gene ID: 359815 ...
... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Many other ...
Biology Products: